About the Foundation
NDI Facts & Statistics
Introduction
Description
Diagnosis & Treatment
History of NDI
Patient/Parent Pages
Overview
Medical Alert Cards
Nutrition Guidelines
Low Sodium Diet Basics
Sodium in Foods (6-9 mo.)
Sodium in Foods (9-12 mo.)
Sodium in Foods (toddlers+)
Label Reading Tips
Family Favorite Recipe Tips
Sodium Content of Selected Foods
Sample Meal Patterns
Low Sodium Cookbooks
General Nutrition Guidelines
Other Low Sodium Info
FAQs
NDI: An Overview
Where can I find support?
Health Care
Medications
Diet and Nutrition
Lithium-induced NDI
Pregnancy and NDI
Growth and Development
Behavioral and Social Concerns
What will happen in the future?
Research
Journal Articles
Publishers
Researchers
Terminology
News & Conferences
Foundation News
Global Conferences
2004 - Phoenix
2002 - Heemskerk
2000 - La Jolla
1999 - Amsterdam
1998 - La Jolla
How Can I Help?
Useful Links
Contact Information
Jean-Pierre Morello
Email:
Phone:
Work (514) 343-6111, Fax (514) 343-2210
Organization:
University of Montreal
Address:
P.O. Box 6128 Downtown Station
Montreal, PQ H3C 3J7
Canada
5 Articles
5 Articles
Pharmacologic Chaperones as a Potential Treatment for X-linked Nephrogenic Diabetes Insipidus
Association of Calnexin With Wild Type and Mutant AVPR2 that Cause Nephrogenic Diabetes Insipidus
Nephrogenic diabetes insipidus.
Pharmacological Chaperones: A New Twist on Receptor Folding
Pharmacological Chaperones Rescue Cell-Surface Expression and Function of Misfolded V2 Vasopressin Receptor Mutants
4 Conference Proceedings
4 Conference Proceedings
Pharmacological chaperones functionally rescue misfolded mutant V2 vasopressin receptors that cause nephrogenic diabetes insipidus
V2 vasopressin receptor mutants responsible for nephrogenic diabetes insipidus associate with the molecular chaperones calnexin and Hsp70
Decrease in urine volume and increase in urine osmolality after SR49059 administration in five adult male patients with X-linked nephrogenic diabetes insipidus
A pharmacological chaperone acting at the V2-vasopressin receptor offers a treatment for Nephrogenic Diabetes Insipidus
5 Articles
5 Articles